NATURAL ANTICOAGULANTS AND COMPLETE BLOOD COUNT INDICES IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

EHA Library, Ahmed Almenshawy, 422158

EFFICACY AND SAFETY OF RIVAROXABAN USE IN GREEK CHILDREN : A SINGLE REFERENCE CENTRE OBSERVATIONAL STUDY

EHA Library, AIKATERINI MICHALOPOULOU, 422159

EXPERT-LED CASE-BASED EDUCATION IN CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA INCREASES COMPETENCE IN IMPROVING LONG-TERM OUTCOMES

EHA Library, Christy Rohani-Montez, 422160

CEREBRAL VEIN THROMBOSIS

EHA Library, Turki Alshuaibi, 422161

YOUNG AND HEALTHY, BUT NOT IMMUNE: A CASE OF THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Pedro Lupi, 422162

HEMOSTASIS-MODULATING EFFECT OF TUMOR MICROENVIRONMENT FACTORS ON THE BLOOD CIRCULATORY BED OF ONCOHEMATOLOGICAL PATIENTS

EHA Library, Vira Barilka, 422163

DESCRIPTION OF A SERIES OF CASES WITH PROTEIN S DEFICIENCY IN THE HEALTH AREA OF TOLEDO (SPAIN).

EHA Library, Ana Camacho Valencia, 422164

INDIRECT EVALUATION OF VASCULAR AND PLATELET HEMOSTASIS IN PATIENTS WITH UNSTABLE ANGINA IN EMERGENCY SETTINGS

EHA Library, Yuliya Tyravska, 422165

STUDY OF THE DEVELOPMENT AND IMPLICATION OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS) IN VASCULAR COMPLICATIONS OF LYSOSOMAL DISEASES.

EHA Library, Irene Serrano-Gonzalo, 422167

THROMBOSIS IN COVID-19 PATIENTS

EHA Library, Turki Alshuaibi, 422168

DESCRIPTIVE ANALYSIS OF A SERIES OF CASES OF HOMOZYGOUS CARRIERS OF THE 46C>T POLYMORPHISM IN THE FACTOR XII GENE.

EHA Library, Karla Susana Calzadilla Román, 422169

ACTIVITY OF BLOOD PLASMA MICROPARTICLES IN PATIENTS WITH LOWER EXTREMITY VASCULAR DISEASE

EHA Library, Olesia Matvienko, 422170

ASSESSMENT OF THROMBIN GENERATION TEST USING ST-GENESIA® IN WOMEN WITH EARLY RECURRENT MISCARRIAGE

EHA Library, Carlos Aguilar, 422171

HEREDITARY ANGIOEDEMA: THE OPTIMISATION OF MOLECULAR STUDIES IN DIFFERENTIAL DIAGNOSTICS

EHA Library, Ivo Barreiros, 422172

PATIENT INTERVIEW–BASED CONTENT VALIDATION OF THE MYELOFIBROSIS SYMPTOM ASSESSMENT FORM VERSION 4.0 (MFSAF V4.0)

EHA Library, Heather Gelhorn, 422175

PHYSICAL ACTIVITY IN RELATION TO SYMPTOM DEVELOPMENT AMONG PATIENTS WITH HEMATOLOGICAL CANCER DURING THEIR FIRST HALF YEAR AFTER DIAGNOSIS

EHA Library, Simone Oerlemans, 422176

MULTIPLE MYELOMA SYMPTOMS RELEVANT TO PATIENTS AND LINKED TO DISEASE PROGRESSION: A SYSTEMATIC LITERATURE REVIEW AND DELPHI PANEL

EHA Library, Martin Kortüm, 422177

QUALITY OF LIFE AFTER IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE IN CHINA: A CROSS-SECTIONAL, MULTI-CENTER SURVEY OF PATIENT REPORTED OUTCOME AND CAREGIVER REPORTED OUTCOME

EHA Library, JIA CHEN, 422178

THE EFFECTIVENESS OF SYNBIOTIC PREPARATION IN PATIENTS WITH NEWLY DIAGNOSED LYMPHOMAS

EHA Library, Mariia Voytko, 422179

BURDEN OF MULTIPLE MYELOMA IN WOMEN: COLOMBIA AND THE REGION OF THE AMERICAS, 2000-2019.

EHA Library, Claudia Lucía Sossa-Melo, 422180

A QUALITATIVE STUDY OF HEMATOLOGICAL CANCER PATIENTS’ HEALTH INFORMATION NEEDS IN KUWAIT

EHA Library, Fatima Khadadah, 422181

QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB TREATMENT IN A REAL-WORLD SETTING

EHA Library, Tatyana Ionova, 422183

UNDERSTANDING THE PATIENT EXPERIENCE IN NON-HODGKIN’S LYMPHOMA; A QUALITATIVE PATIENT INTERVIEW STUDY

EHA Library, Sophie Van Tomme, 422184

COMPARATIVE EVALUATION OF QUALITY OF LIFE IN HEMOPHILIA A PATIENTS UNDER PROPHYLAXIS: A 4-YEAR PERSPECTIVE

EHA Library, Nikolaos Kotsiou, 422185

CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION CAUSED NO SIGNIFICANT PATIENT-REPORTED SHORTNESS OF BREATH: FINDINGS FROM THE CONPET STUDY

EHA Library, Lene Kongsgaard Nielsen, 422186

IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE  SYMPTOM BURDEN SCALE (ISBUS): PROTOCOL FOR THE DEVELOPMENT OF A NOVEL STANDARDIZED PATIENT REPORTED OUTCOME MEASURE

EHA Library, Philip Powell, 422187

LEUKEMIA BURDEN IN THE COLOMBIAN POPULATION AND ITS CONTEXT IN THE REGION OF THE AMERICAS, 2000-2019.

EHA Library, Claudia Lucía Sossa-Melo, 422188

DEVELOPMENT OF NUTRITIONAL SCREENING FOR ONCOLOGY OUTPATIENTS: NSOO-2024

EHA Library, Celso Arrais-Rodrigues, 422189

EFFECTS OF AN EXERCISE THERAPY ON PHYSICAL FUNCTIONING AND QUALITY OF LIFE DURING ADULT UMBILICAL CORD BLOOD TRANSPLANTATION: A RANDOMIZED CONTROLLED TRIAL

EHA Library, Chengzhen Jia, 422190

BURNOUT AMONG PALLIATIVE CARE DOCTORS IN ONCO-HEMATOLOGY

EHA Library, rihab ben sghaier, 422191

STUDY ON THE EFFECT OF GUIZHI FULING DECOCTION ON CHEMOTHERAPY-RELATED PERIPHERAL NEUROPATHY BY REGULATING METTL3/LET-7/NGF AXIS

EHA Library, xing cui, 422192

NURSING CARE OF A LYMPHOMA PATIENT WITH COVID-19 INFECTION UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH CAR-T TREATMENT

EHA Library, Liu Tingting, 422193

CLINICAL HEMATOLOGY CAREGIVING STAFF: WHAT IMPACT ON PERSONAL AND PROFESSIONAL LIFE?

EHA Library, kenza Darkaoui, 422194

FINANCIAL BURDEN OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA IN NORTH MACEDONIA IN THE ERA OF NOVEL IMMUNOTHERAPIES

EHA Library, Nevenka Ridova, 422195

SUSTAINED COST-EFFECTIVENESS OF BREXUCABTAGENE AUTOLEUCEL FOR THE TREATMENT OF RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN PATIENTS AGED 26 YEARS OR OLDER IN ITALY

EHA Library, Monia Marchetti, 422196

THE INFLUENCE OF SOCIOECONOMIC FACTORS ON MORTALITY IN ACUTE MYELOID LEUKEMIA - AN INDIAN PERSPECTIVE

EHA Library, Priscilla Nethala, 422197

HEALTH ECONOMIC IMPACT OF SECOND-LINE INTERVENTIONS OF DIFFUSE LARGE B-CELL LYMPHOMA FOR TRANSPLANT-INELIGIBLE PATIENTS IN GERMANY

EHA Library, Melina Sophie Kurte, 422198

INNOVATIVE LABEL-FREE LYMPHOMA DIAGNOSIS USING INFRARED SPECTROSCOPY AND MACHINE LEARNING ON TISSUE SECTIONS

EHA Library, Sander De Bruyne, 422199

COMMUNITY: A NOVEL R-TOOL FOR DIFFERENTIAL COMMUNICATION ANALYSIS IN HUMAN BONE MARROW SCRNASEQ DATA OF AML PATIENTS IN A CASE-CONTROL DESIGN

EHA Library, Muhammet Celik, 422200

RISK FACTORS FOR SURVIVAL AND A PREDICTIVE MODEL OF INFUSION-RELATED REACTION IN B-CELL LYMPHOMA PATIENTS RECEIVING OBINUTUZUMAB

EHA Library, Shijie Li, 422201

TOWARDS AUTOMATED CYTOMORPHOLOGY ANALYSIS IN BONE MARROW SAMPLES: ARTIFICIAL INTELLIGENCE CAN INCREASE THE PRECISION OF BLAST COUNT

EHA Library, Miguel Gomez, 422202

AI-BASED AUTOMATION OF BONE MARROW PLASMA CELL QUANTIFICATION: IMPLICATIONS OF REDUCING VARIABILITY FOR MULTIPLE MYELOMA DIAGNOSIS

EHA Library, Ana Mendoza, 422203

PHASE 3 STUDY RESULTS OF ISATUXIMAB, BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (ISA-VRD) VERSUS VRD FOR TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (IMROZ)

EHA Library, Thierry Facon, 422204

THE LANDSCAPE OF TP53 MUTATIONS AND THEIR PROGNOSTIC IMPACT IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Consuelo Bertossi, 422205

FIRST RESULTS OF THE APOLLO TRIAL: A RANDOMIZED PHASE III STUDY TO COMPARE ATO COMBINED WITH ATRA VERSUS STANDARD AIDA REGIMEN FOR PATIENTS WITH NEWLY DIAGNOSED, HIGH-RISK ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Uwe Platzbecker, 422206

ASCIMINIB (ASC) PROVIDES SUPERIOR EFFICACY AND EXCELLENT SAFETY AND TOLERABILITY VS TYROSINE KINASE INHIBITORS (TKI) IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) IN THE PIVOTAL ASC4FIRST STUDY

EHA Library, Andreas Hochhaus, 422207

ENERGIZE: A GLOBAL PHASE 3 STUDY OF MITAPIVAT DEMONSTRATING EFFICACY AND SAFETY IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA

EHA Library, Ali T. Taher, 422208

OVERCOMING MICROENVIRONMENT-MEDIATED RESISTANCE IN PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA WITH THE NOVEL AMINO ACID DEGRADER CYST(E)INASE

EHA Library, Richard Burt, 422209

BCL-XL INHIBITOR, NAVITOCLAX, ENHANCES THE EFFICACY OF INDUCTION CHEMOTHERAPY IN PRECLINICAL MODELS OF RELAPSED PAEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Mankaran Singh, 422210

MASTER ONCOGENE NOTCH1 CONFERS A VULNERABILITY TO FERROPTOSIS IN HEMATOLOGICAL CANCERS

EHA Library, Guillaume Andrieu, 422211

TRANSCRIPTIONAL REPROGRAMMING SHAPES ALL RESPONSE TO NECROPTOTIC CELL DEATH

EHA Library, Anna Saorin, 422212

NOVEL APPROACH FOR FERROPTOSIS INDUCTION AND OVERCOMING CHEMORESISTANCE IN B-ALL VIA TARGETING POLO-LIKE KINASE

EHA Library, Pawel Stachura, 422213

WU-CART-007, AN ALLOGENEIC CAR-T CELL TARGETING CD7, IS HIGHLY EFFECTIVE AGAINST RELAPSED/REFRACTORY (R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA (T-ALL/LBL)

EHA Library, Ibrahim Aldoss, 422214

BLINATUMOMAB FOR FIRST LINE TREATMENT IN INTERMEDIATE AND HIGH RISK DOWN SYNDROME B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA: INITIAL FINDINGS FROM THE ALLTOGETHER1 DS TRIAL

EHA Library, Sujith Samarasinghe, 422215

BLINATUMOMAB AS CONSOLIDATION IN A PAEDIATRIC PROTOCOL LEADS TO HIGH RATES OF END-CONSOLIDATION MRD NEGATIVITY AND EXCELLENT OUTCOMES IN AYA ALL – FINAL RESULTS OF THE ALLG ALL09 "SUBLIME" STUDY

EHA Library, Matthew Greenwood, 422216

BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN ADULT B-ALL: A COMPARISON OF THE CONSECUTIVE HOVON-100 AND H-146 STUDIES

EHA Library, Anita Rijneveld, 422217

OBECABTAGENE AUTOLEUCEL IN ADULT RELAPSED/REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA: SURVIVAL AND POTENTIAL IMPACT OF CAR-T CELL PERSISTENCE AND STEM CELL TRANSPLANTATION IN THE FELIX STUDY

EHA Library, Claire Roddie, 422218

PONATINIB VERSUS IMATINIB IN PATIENTS WITH NEWLY DIAGNOSED PH+ ACUTE LYMPHOBLASTIC LEUKEMIA IN THE PHASE 3 PHALLCON TRIAL: IN-DEPTH RESPONDER ANALYSIS

EHA Library, Jose-Maria Ribera, 422219

EARLY RESPONSE REFINES END OF INDUCTION MEASURABLE RESIDUAL DISEASE STRATIFICATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Ozcan Gulbey, 422220

VENETOCLAX IN COMBINATION WITH THE PEDIATRIC-INSPIRED REGIMEN FOR THE TREATMENT OF NEWLY DIAGNOSED ADULTS WITH PH-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): A PHASE 1 STUDY WITH AN EXPANSION COHORT

EHA Library, Ibrahim Aldoss, 422221

COMPREHENSIVE NEXT GENERATION SEQUENCING-BASED PROFILING OF IMMUNOGLOBULIN (IG) AND T-CELL RECEPTOR (TR) REARRANGEMENTS IN ALL IDENTIFIES CLONAL EVOLUTION AND AGE-RELATED PATTERNS

EHA Library, Monika Brüggemann, 422222

IMMUNE RECONSTITUTION AFTER CD7 CAR-T CELL THERAPY FOR REFRACTORY /RELAPSED ACUTE T-LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(R/R T-ALL/LBL)

EHA Library, Xian Zhang, 422223

PHARMACOLOGICAL INHIBITION OF METTL1 AS A NOVEL THERAPEUTIC STRATEGY AGAINST AML

EHA Library, Eliza Yankova, 422224

UNCOVERING THE POTENTIAL OF THE PA2G4-MYC AXIS AS A TARGET IN 3Q26 ACUTE MYELOID LEUKEMIA

EHA Library, Giovanni Roti, 422225

IDENTIFICATION OF FOUR LEUKEMIC STEM CELL TYPES REVEALS DISTINCT AND COMMON RESISTANCE MECHANISMS TO VENETOCLAX/HYPOMETHYLATING AGENTS AND CHEMOTHERAPY

EHA Library, Alexander Waclawiczek, 422226

HIGH TUMOUR INTRINSIC EXPRESSION OF STING IS ASSOCIATED WITH POTENT AND TP53 INDEPENDENT PRO-APOPTOTIC ACTIVITY BY STING AGONISTS IN AML

EHA Library, Yin Yuan, 422227

CPSF6-RARG FUSION COOPERATES HDAC3 TO PROMOTE MYELOID TRANSFORMATION BY DOWNREGULATING PU.1

EHA Library, Tanzhen Wang, 422228

KMT2A-MLLT3-INDUCED LEUKAEMIA CHANGES DURING ONTOGENIC STAGES

EHA Library, Meaad Almowaled, 422229

CHROMATIN ACCESSIBILITY PROFILING REVEALS EPIGENETIC HETEROGENEITY IN ACUTE MYELOID LEUKEMIA

EHA Library, Yotaro Ochi, 422230

THE ONCOGENIC ACTIVITY OF THE INTRINSICALLY DISORDERED TRANSCRIPTIONAL REGULATOR MN1 RELIES ON THE CHAPERONE DNAJB6B IN ACUTE MYELOID LEUKEMIA

EHA Library, Diego A Pereira-Martins, 422231

MEGAKARYOBLASTIC LEUKEMIA SPECIFIC DEPENDENCY ON LONG NON-CODING RNA SNHG29

EHA Library, Robert Winkler, 422232

PREEMPTIVE TARGETING OF PRELEUKEMIC CELLS IN DOWN SYNDROME WITH PATHWAY-DIRECTED THERAPIES: A NOVEL APPROACH TO PREVENT MYELOID LEUKEMIA

EHA Library, Anna-Lena Schmell, 422233

THE NOVEL MENIN INHIBITOR ZE63-0302 HAS AN IMPRESSIVE SAFETY PROFILE AND UNIQUE CHEMISTRY THAT SUGGESTS IMPROVED EFFICACY AGAINST RESISTANCE MUTATIONS.

EHA Library, Erin Hertlein, 422234

FIRST-IN-HUMAN PHASE 1/2 STUDY OF THE MENIN-MLL INHIBITOR DSP-5336 IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LEUKEMIA: UPDATED RESULTS FROM DOSE ESCALATION

EHA Library, Naval Daver, 422236

A PHASE 1B STUDY OF THE MENIN-KMT2A INHIBITOR JNJ-75276617 IN COMBINATION WITH VENETOCLAX AND AZACITIDINE IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA WITH ALTERATIONS IN KMT2A OR NPM1

EHA Library, Andrew H. Wei, 422237

PHASE 1B STUDY OF AZACITIDINE, VENETOCLAX AND REVUMENIB IN NEWLY DIAGNOSED OLDER ADULTS WITH NPM1 MUTATED OR KMT2A REARRANGED AML: INTERIM RESULTS OF DOSE ESCALATION FROM THE BEATAML CONSORTIUM

EHA Library, Joshua Zeidner, 422238

VENETOCLAX-BASED SALVAGE TREATMENT FOR RELAPSED/REFRACTORY AML USING A COMBINATION WITH HIGH-DOSE CYTARABINE AND MITOXANTRONE (HAM-VEN): UPDATED RESULTS OF THE PHASE-I/II SAL RELAX TRIAL

EHA Library, Leo Ruhnke, 422239

FLAG-IDA + VENETOCLAX (VEN) IN NEWLY DIAGNOSED (ND) OR RELAPSED / REFRACTORY (RR) AML

EHA Library, Wei-Ying Jen, 422240

VENETOCLAX-HMA AS A BRIDGE TOWARDS HSCT OR DLI IN R/R AML: A RETROSPECTIVE ANALYSIS IN 20 HOSPITALS ACROSS THE NETHERLANDS

EHA Library, Kathelijn Verdeyen, 422241

MAGROLIMAB VS PLACEBO IN COMBINATION WITH VENETOCLAX AND AZACITIDINE IN PREVIOUSLY UNTREATED PATIENTS WITH ACUTE MYELOID LEUKEMIA WHO ARE INELIGIBLE FOR INTENSIVE CHEMOTHERAPY: THE ENHANCE-3 STUDY

EHA Library, Naval Daver, 422242

PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE WITH VENETOCLAX AND GILTERITINIB IN PATIENTS WITH NEWLY DIAGNOSED AND RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Alex Bataller, 422243

LLS 2024 ELN-REFINED RISK STRATIFICATION IN OLDER ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA TREATED WITH LOW-INTENSITY THERAPY

EHA Library, Fieke Hoff, 422244

A POST HOC ANALYSIS OF OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES WHO RECEIVED ORAL AZACITIDINE MAINTENANCE THERAPY IN THE QUAZAR AML-001 STUDY

EHA Library, Maria Teresa Voso, 422245

QUANTUM-FIRST: EFFICACY IN NEWLY DIAGNOSED PATIENTS WITH FMS-LIKE TYROSINE KINASE 3-INTERNAL TANDEM DUPLICATION–POSITIVE (FLT3-ITD+) ACUTE MYELOID LEUKEMIA (AML) WHO RECEIVED CONTINUATION THERAPY

EHA Library, Mikkael A. Sekeres, 422246

DISEASE CHARACTERISTICS AND OUTCOME OF ACUTE MYELOID LEUKEMIA IN FAMILIAL PLATELET DISORDER WITH ASSOCIATED MYELOID MALIGNANCY

EHA Library, Martijn Ernst, 422247

OLUTASIDENIB FOR MUTATED IDH1 ACUTE MYELOID LEUKEMIA: FINAL FIVE-YEAR RESULTS FROM THE PHASE 2 PIVOTAL COHORT

EHA Library, Jorge Cortes, 422248

GENETIC INSIGHTS INTO ACQUIRED RESISTANCE AND CLONAL EVOLUTION IN VENETOCLAX (VEN)-BASED THERAPY FOR ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Marina Konopleva, 422249

COMPLETED DOSE ESCALATION FROM THE FIRST-IN-HUMAN, PHASE 1/2 STUDY OF CD123 NK CELL ENGAGER, SAR443579, IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA OR HIGH RISK-MYELODYSPLASIA

EHA Library, Sylvain Garciaz, 422250

ADVERSE PROGNOSTIC IMPACT OF SECONDARY-TYPE MUTATIONS IN ELN 2022 FAVORABLE RISK ACUTE MYELOID LEUKEMIA

EHA Library, Dimitrios Kotsos, 422251

GENOMIC LANDSCAPE OF ADULT AML WITH T(8;21)(Q22;Q22.1) AND PROGNOSTIC IMPLICATIONS – RESULTS FROM THE HARMONY PLATFORM

EHA Library, Alberto Hernandez-Sanchez, 422252

MINI-CONSOLIDATIONS VERSUS INTERMEDIATE-DOSE CYTARABINE (IDAC) FOR THE POST-REMISSION THERAPY OF AML PATIENTS OVER 60. A STUDY FROM THE DATAML AND SAL REGISTRIES.

EHA Library, Christian Récher, 422253

COMPREHENSIVE FUNCTIONAL ANALYSES OF LEF1 IDENTIFY PROTEIN ABUNDANCE AND ALTERNATIVE ISOFORM EXPRESSION AS DRIVERS OF CELL PROLIFERATION IN AGGRESSIVE CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Judith Mateos-Jaimez, 422254

SINGLE-CELL ANALYSES AND FUNCTIONAL IN VIVO STUDIES IDENTIFY IMMATURE SUPPRESSIVE NEUTROPHILS THAT LIMIT T-CELL CONTROL OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Martina Seiffert, 422255

INTEGRATIVE SINGLE-CELL ANALYSES OF CIRCULATING CELLS FROM LEUKEMIC AND HEALTHY SIBLINGS IN FAMILIAL FORMS OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Mira CHEMLA KUZMIC, 422256

CD49D DEFICIENCY IN A CHRONIC LYMPHOCYTIC LEUKEMIA MODEL INDUCES CONSTITUTIVE B CELL RECEPTOR KINASE ACTIVATION, RESULTING IN ANTIGEN UNRESPONSIVENESS

EHA Library, Laura Polcik, 422257

FIRST-IN-CLASS MTHFD1 INHIBITOR ELIMINATES MALIGNANT B CELLS IN VITRO AND IN VIVO

EHA Library, Elodie Viry, 422258

LATEST RESULTS FROM AN ONGOING FIRST-IN-HUMAN PHASE 1A/B STUDY OF NX-5948, A SELECTIVE BRUTON’S TYROSINE KINASE (BTK) DEGRADER, IN PATIENTS WITH RELAPSED/REFRACTORY CLL AND OTHER B-CELL MALIGNANCIES

EHA Library, Kim Linton, 422259

RESULTS FROM THE PHASE 1 STUDY OF THE NOVEL BCL2 INHIBITOR SONROTOCLAX (SONRO) IN COMBINATION WITH ZANUBRUTINIB (ZANU) FOR RELAPSED/REFRACTORY (R/R) CLL/SLL SHOW DEEP AND DURABLE RESPONSES

EHA Library, Stephen Opat, 422260

PRELIMINARY EFFICACY AND SAFETY OF THE BRUTON TYROSINE KINASE (BTK) DEGRADER BGB-16673 IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CLL/SLL: RESULTS FROM THE PHASE 1 BGB-16673-101 STUDY

EHA Library, Ricardo Parrondo, 422261

CHARACTERISTICS ASSOCIATED WITH RESPONSE TO LISOCABTAGENE MARALEUCEL (LISO‑CEL) IN PATIENTS (PTS) WITH R/R CLL/SLL: EXPLORATORY ANALYSES FROM TRANSCEND CLL 004

EHA Library, William G. Wierda, 422262